Physician

Howard S. Lazarus, M.D.

According to 2025 Medicare claims, Howard Lazarus, M.D. (NPI: 1063411635) practices ophthalmology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Jefferson, KY. This provider's primary affiliated billing organization is JOHN KENYON AMERICAN EYE INSTITUTE LLC (NPI: 1447259510; TIN: 351907389) and primary practice location at 47150-3620.

Lazarus' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 28,855 HCPCS/CPT codes, and received $2,156,992 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,103 prescription claims across 253 beneficiaries totaling $103,656 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 16 records totaling $504. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $1,502,728 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,458,346 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,588,210 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,658,100 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,753,885 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,770,890 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,076,270 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,979,818 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,948,078 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,156,992 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159958,592$1,502,728
20161,0708,620$1,458,346
20171,0628,895$1,588,210
20189978,775$1,658,100
20199648,614$1,753,885
20208507,825$1,770,890
20218868,383$2,076,270
20228499,491$1,979,818
202376019,249$1,948,078
202474128,855$2,156,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$71K$143K2015 Drug cost: $96,811 (USD; Tot_Drug_Cst)2016 Drug cost: $112,142 (USD; Tot_Drug_Cst)2017 Drug cost: $125,133 (USD; Tot_Drug_Cst)2018 Drug cost: $127,697 (USD; Tot_Drug_Cst)2019 Drug cost: $111,027 (USD; Tot_Drug_Cst)2020 Drug cost: $121,055 (USD; Tot_Drug_Cst)2021 Drug cost: $134,039 (USD; Tot_Drug_Cst)2022 Drug cost: $142,750 (USD; Tot_Drug_Cst)2023 Drug cost: $121,050 (USD; Tot_Drug_Cst)2024 Drug cost: $103,656 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015210741$96,811
2016247881$112,142
2017245936$125,133
2018253952$127,697
2019222907$111,027
2020232912$121,055
2021259952$134,039
20222681,001$142,750
2023232875$121,050
20242531,103$103,656

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2531,002$93
92014Established patient complete exam of visual system506711$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more318783$64
92134Imaging of retina4521,194$28
92250Photography of the retina345514$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost553,205$25,243
RestasisCyclosporine291,230$24,715
CombiganBrimonidine Tartrate/Timolol411,773$9,642
Prednisolone AcetatePrednisolone Acetate1584,715$4,574
DifluprednateDifluprednate501,373$3,694

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$331Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.3$173Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Howard S. Lazarus, M.D.?

Tedicare shows public-source Medicare data for Howard S. Lazarus, M.D. (NPI 1063411635), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Howard S. Lazarus, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Howard S. Lazarus, M.D.?

Howard S. Lazarus, M.D. is linked to JOHN KENYON AMERICAN EYE INSTITUTE LLC (billing NPI 1447259510) in the available physician profile data.

Does Howard S. Lazarus, M.D. have Open Payments data?

Howard S. Lazarus, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.